Seminars in Nuclear Medicine
Volume 32, Issue 1 , Pages 60-69, January 2002

18F-deoxyglucose and the assessment of myocardial viability†

  • Heinrich R. Schelbert

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Heinrich R. Schelbert, MD, UCLA School of Medicine, 23-120 CHS, Los Angeles, CA 90095-1735.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

† Operated for the US Department of Energy by the University of California under contract DE-AC03-76-SF00012. Supported in part by the Director of the Office of Energy Research, Office of Health and Environmental Research, Washington, DC, and by Research Grant HL 33177, National Institutes of Health, Bethesda, MD.

PII: S0001-2998(02)80040-X

doi:10.1053/snuc.2002.29274

Seminars in Nuclear Medicine
Volume 32, Issue 1 , Pages 60-69, January 2002

Article Tools